High survival rates in localized kidney cancer contrast with patients' uncertainty about their prognosis, affecting their quality of life. The distinction between feeling "cured" and "consumed" by ...

Earlier analyses demonstrated strong local tumor control, with nearly nine in 10 patients remaining free of recurrence at ...

The targeted drug nivolumab significantly prolongs survival in patients with advanced kidney cancer, whose disease has progressed after their first treatment, according to results to be presented at ...

SALT LAKE CITY — The five-year survival rate for all cancers combined has reached a historic 70%, according to the latest American Cancer Society Cancer Statistics 2026 report, based on all people ...

Routine cancer screenings, improved treatments, and less smoking are the main reasons why 7 in 10 cancer patients are reaching the 5-year survival milestone, a new report shows. Almost 70 percent of ...